100% Quality Guarantee
PhD-Level Technical Support
Key Features

Human CXCL7/NAP-2 Recombinant Protein (RPES1406)

SKU RPES1406
Product Type Recombinant Protein
Species Human
Application Area Cytokines & Chemokines
€357 - €936

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Human CXCL7/NAP-2 Recombinant Protein

Human Chemokine (C-X-C motif) Ligand 7 (CXCL7); also known as neutrophil activating peptide 2 (NAP-2); is a member of the CXC chemokines containing an ELR domain (Glu-Leu-Arg tripeptide motif). CXCL7 binds CXCR2, which is similar to other ELR chemokines such as IL-8 and the GRO proteins; it attracts and activates neutrophils. CXCL7; Connective Tissue Activating Protein III (CTAPIII) and beta thrombogulin (beta-TG); are proteolytically processed carboxylterminal fragments of platelet basic protein (PBP) which is found in the alphagranules of human platelets. However, because beta TG, CTAPIII, and PBP are amino-terminal extended versions of NAP2 with the same CXC chemokine domains as NAP2, they do not have CXCL7/NAP2 activity. CXCL7 activates CXCR-2, which is a G protein-coupled receptor. Human CXCL7/NAP-2 Recombinant Protein is a highly pure recombinant protein developed by Assay Genie for use in a range of applications.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose